Drug Shortage Report for EMLA CREAM
Report ID | 209402 |
Drug Identification Number | 00886858 |
Brand name | EMLA CREAM |
Common or Proper name | lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE PRILOCAINE |
Strength(s) | 2.5% 2.5% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 1 Tube |
ATC code | D04AB |
ATC description | ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-12-15 |
Actual start date | 2023-12-20 |
Estimated end date | 2024-01-15 |
Actual end date | 2024-01-08 |
Shortage status | Resolved |
Updated date | 2024-01-18 |
Company comments | VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2024-01-18 | French | Compare |
v15 | 2024-01-18 | English | Compare |
v14 | 2024-01-04 | French | Compare |
v13 | 2024-01-04 | English | Compare |
v12 | 2023-12-21 | English | Compare |
v11 | 2023-12-19 | French | Compare |
v10 | 2023-12-19 | English | Compare |
v9 | 2023-12-16 | English | Compare |
v8 | 2023-12-12 | French | Compare |
v7 | 2023-12-12 | English | Compare |
v6 | 2023-12-12 | English | Compare |
v5 | 2023-12-02 | English | Compare |
v4 | 2023-12-01 | French | Compare |
v3 | 2023-12-01 | English | Compare |
v2 | 2023-11-06 | French | Compare |
v1 | 2023-11-06 | English | Compare |
Showing 1 to 16 of 16